Therapy for Depression With Co-occurring Panic or Anxiety Symptoms
Interpersonal Psychotherapy for Depression With Co-occurring Panic and Anxiety Symptoms (IPT-PS)
2 other identifiers
interventional
36
1 country
1
Brief Summary
This 6-month study, with a 3-month follow up period, will compare the effectiveness of new and traditional psychotherapies for depression with panic or anxiety symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1 depression
Started Nov 2002
Typical duration for phase_1 depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2002
CompletedFirst Submitted
Initial submission to the registry
January 7, 2003
CompletedFirst Posted
Study publicly available on registry
January 8, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2005
CompletedJune 25, 2013
December 1, 2007
January 7, 2003
June 21, 2013
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- DSM-IV diagnosis of major depression with co-existing panic or anxiety symptoms.
You may not qualify if:
- History of manic episode(s). Patients who have had hypomanic episodes in the past will be accepted into the study, provided they meet other admission criteria and are not presenting in a current hypomanic or mixed episode.
- History of schizophrenia or schizoaffective disorder.
- Organic affective syndrome.
- Unspecified functional psychosis.
- Anorexia nervosa or bulimia nervosa. Patients meeting criteria for an eating disorder not otherwise specified will not be excluded.
- Chronic drug or alcohol abuse/dependence within the past 2 years. Patients with abuse related to episodes will not be excluded.
- DSM-IV criteria for borderline or antisocial personality disorder. Patients who meet criteria for other Axis II disorders will not be excluded.
- Inpatient treatment due to suicide risk or psychotic symptoms.
- Index episode secondary to the effect of medically prescribed drugs.
- Significant or untreated medical illness, including cardiovascular disorder, renal or liver disease, epilepsy, untreated hypertension, or unstabilized endocrine disease.
- Medical illness that would interfere with the best treatment strategy for the potential participant.
- Current treatment with an antidepressant. Patients on a stable dose of anxiolytics for at least 3 months prior to study participation who are able to maintain this dosage throughout the study will not be excluded.
- Pregnant and breast-feeding women will be accepted into the study, but will not be prescribed adjunctive medications.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Western Psychiatric Institute and Clinic - Depression and Manic Depression Program
Pittsburgh, Pennsylvania, 15213, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 7, 2003
First Posted
January 8, 2003
Study Start
November 1, 2002
Study Completion
August 1, 2005
Last Updated
June 25, 2013
Record last verified: 2007-12